Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Bonifacius, Agnes; Lamottke, Britta; Tischer-Zimmermann, Sabine et al.
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsJOURNAL OF CLINICAL INVESTIGATION. Bd. 133. H. 12. 2023
Schmidt, Marcus; Denkert, Carsten; Rhiem, Kerstin et al.
Personalized medicine-from translational research to clinical practiceGYNAKOLOGIE. Bd. 56. H. 5. 2023 S. 341-346
Depenbusch, Johanna; Sweegers, Maike G.; Aaronson, Neil K. et al.
PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countriesSUPPORTIVE CARE IN CANCER. Bd. 31. H. 5. 2023
Brose, Alexander; Michalski, Kerstin; Ruf, Juri et al.
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohortCANCER IMAGING. Bd. 23. H. 1. 2023
Nastoupil, Loretta J.; Hess, Georg; Pavlovsky, Miguel A. et al.
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphomaBLOOD ADVANCES. Bd. 7. H. 22. 2023 S. 7141-7150
Maas, Anne; Maurice-Stam, Heleen M.; van der Aa-van Delden, Alied C. et al.
Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology studyJOURNAL OF CANCER SURVIVORSHIP. 2023
Maas, Anne; Maurice-Stam, Heleen; Van der Aa-Van Delden, Alied et al.
POSITIVE AND NEGATIVE SURVIVOR-SPECIFIC PSYCHOSOCIAL CONSEQUENCES OF CHILDHOOD CANCER: THE DCCSS-LATER 2 PSYCHO-ONCOLOGY STUDYPEDIATRIC BLOOD & CANCER. Bd. 70. 2023 S. S16-S16
Ernst, Mareike; Werner, Antonia M.; Brahler, Elmar et al.
Posttraumatic growth after childhood cancer: Psychometric evaluation of a five-item short form and associations with mental healthJOURNAL OF PSYCHOSOMATIC RESEARCH. Bd. 164. 2023
Degenhardt, Tom; Fasching, Peter A.; Lueftner, Diana et al.
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrantTRIALS. Bd. 24. H. 1. 2023
Herbert, Saskia-Laureen; Flock, Felix; Felberbaum, Ricardo et al.
Predictors of Decreased Quality of Life in Breast Cancer Survivors Five Years After DiagnosisJOURNAL OF BREAST CANCER. Bd. 26. H. 3. 2023 S. 243-253